Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study
Bo Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ke Wang(Capital Medical University), Qian Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Junyan Yu(Changzhi Medical College), Yiwei Dou(New York University), Zhixiang Zhuang(Soochow University), Yongqian Shu(Jiangsu Province Hospital), Xiaoge Kou(First Affiliated Hospital of Xinxiang Medical University), Yuxian Bai(Harbin Medical University), Shan Zeng(Central South University), Zhihui Liu(Jilin University), Shengmian Li(Hebei Medical University), Shu Zhang(Tianjin University of Technology), Xiaodong Zhu(Fudan University Shanghai Cancer Center), Hui Wang(Sun Yat-sen University), Haijun Zhong(Zhejiang Cancer Hospital), Fen Wang(Texas A&M Health Science Center), Jingdong Zhang(Liaoning Cancer Hospital & Institute), Qingxia Fan(First Affiliated Hospital of Zhengzhou University), Yan Song(Shandong Eye Hospital), Taiyang Ma, Yifu He(Anhui Provincial Hospital), Xianli Yin(Central South University), Nong Xu(Zhejiang University), Yunpeng Liu(Shenyang Institute of Automation), Enxiao Li(First Affiliated Hospital of Xi'an Jiaotong University), Xinjun Liang(Hubei Cancer Hospital), Suxia Luo(Henan Cancer Hospital)
Cited by 6
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k